Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin

Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin

Detaylı Bibliyografya
Asıl Yazarlar:	Mahtani, K, Nunan, D, Heneghan, C
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BMJ Publishing Group 2015

Benzer Materyaller

Vitamin K for improved anticoagulation control in patients receiving warfarin
Yazar:: Mahtani, K, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Cochrane corner: self-monitoring and self-management of oral anticoagulation.
Yazar:: Heneghan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Optimal loading dose of warfarin for the initiation of oral anticoagulation.
Yazar:: Mahtani, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
Yazar:: Jo-Nan Liao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
Yazar:: Hyun-Jung Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Physical activity interventions and chronic diseases: A matched-pair analysis comparing Cochrane and non-Cochrane Systematic Reviews
Yazar:: Hacke, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Cochrane corner: water for wound cleansing.
Yazar:: Henton, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cochrane corner: water for wound cleansing.
Yazar:: Henton, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Baskı/Yayın Bilgisi: (2020-02-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Yazar:: Mu-Mei Hu, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Yazar:: Huei‐Kai Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
Yazar:: Seong Huan Choi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation
Yazar:: Seong Huan Choi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
Yazar:: Hsin‐Fu Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
Yazar:: Heng Cai, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
Yazar:: Celine Gallagher, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study
Yazar:: Andrea L Jorgensen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Cochrane Corner: Coronavirus (COVID-19): infection control and prevention measures
Yazar:: Vanessa Jordan
Baskı/Yayın Bilgisi: (2020-01-01)

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
Yazar:: MuHyung Heo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Comparison of ََQuality of Life and Treatment Satisfaction among Sample of Iraqi Patients Using Anticoagulant Therapy (Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants)
Yazar:: Basma Z. Al-Metwali, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Anticoagulation Management in Patients Receiving Warfarin at Private Cardiac Centers in Addis Ababa, Ethiopia
Yazar:: Getachew R, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Cochrane Corner: Withdrawal of antihypertensive drugs in older people
Yazar:: Filipa Reis, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
Yazar:: Salih Kilic, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia
Yazar:: Nuredin Shiferaw Yimer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism
Yazar:: Catherine A Saint, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Patient adherence to warfarin therapy and its impact on anticoagulation control
Yazar:: Ahmed Y. Mayet
Baskı/Yayın Bilgisi: (2016-01-01)

Cochrane corner: antibiotic prophylaxis for mammalian bites (intervention review).
Yazar:: Henton, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cochrane corner: antibiotic prophylaxis for mammalian bites (intervention review).
Yazar:: Henton, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cochrane Corner: colchicina na pericardite aguda e recorrente
Yazar:: Daniel Caldeira, ve diğerleri
Baskı/Yayın Bilgisi: (2015-11-01)

O Cochrane Corner da Revista Portuguesa de Cardiologia
Yazar:: António Vaz Carneiro
Baskı/Yayın Bilgisi: (2013-11-01)

Vitamina K: metabolismo, fontes e interação com o anticoagulante varfarina Vitamin K: metabolism, sources and interaction with the anticoagulant warfarin
Yazar:: Karin Klack, ve diğerleri
Baskı/Yayın Bilgisi: (2006-12-01)

Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
Yazar:: Sha Qiu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
Yazar:: I. Yu. Koroleva, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review
Yazar:: Tamrat Assefa Tadesse, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
Yazar:: Saga Itäinen‐Strömberg, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
Yazar:: Yuqing Deng, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis.
Yazar:: Mahtani, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic
Yazar:: Ubonwan Sapoo, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Management of haemorrhage in patients receiving non-vitamin-k oral anticoagulants treatment: Case report
Yazar:: Rangelov-Kulezić Jasmina, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist
Yazar:: Dung Chu S, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)